Literature DB >> 17996305

Anti-idiotypic response in mice expressing human autoantibodies.

Roberto Di Niro1, Daniele Sblattero, Fiorella Florian, Marco Stebel, Lorena Zentilin, Mauro Giacca, Vincenzo Villanacci, Anna Galletti, Tarcisio Not, Alessandro Ventura, Roberto Marzari.   

Abstract

Celiac disease is an autoimmune illness characterized by intestinal mucosal injury and malabsorption precipitated by dietary exposure to gluten of some cereals. The immune response is based on both cellular and humoral components, although the former seem to be more important in the pathogenesis. The autoantibody response is directed at the enzyme tissue transglutaminase, tTG or TG2, which possibly play a role in the onset of the disease. In this study we sought to develop an animal model in which to analyze the immunological regulation and significance of anti-TG2 antibodies, by expressing specific human single-chain antibody fragments in mice using adeno-associated virus vectors. Upon vector injection in the skeletal muscles, high and persistent systemic levels of anti-TG2 antibodies were obtained. Mice injected with vectors encoding antibodies also recognizing rodent TG2, also developed a strong anti-idiotypic response. This finding raises the question of whether an anti-idiotypic response to anti-TG2 antibodies is a factor associated with celiac disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996305     DOI: 10.1016/j.molimm.2007.09.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

Review 1.  Antibodies in celiac disease: implications beyond diagnostics.

Authors:  Sergio Caja; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

3.  Development and Characterization of a Neutralizing Anti-idiotype Antibody Against Mirvetuximab for Analysis of Clinical Samples.

Authors:  Sven Loebrich; Mingfang Shen; Erika Cohen; Gillian Payne; Ying Chen; Megan Bogalhas; Yiwei Zhao
Journal:  AAPS J       Date:  2017-05-22       Impact factor: 4.009

4.  Injection of celiac disease patient sera or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease.

Authors:  Suvi Kalliokoski; Sergio Caja; Rafael Frias; Kaija Laurila; Outi Koskinen; Onni Niemelä; Markku Mäki; Katri Kaukinen; Ilma R Korponay-Szabó; Katri Lindfors
Journal:  J Mol Med (Berl)       Date:  2014-09-12       Impact factor: 4.599

5.  Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases.

Authors:  F Ferrara; S Quaglia; I Caputo; C Esposito; M Lepretti; S Pastore; R Giorgi; S Martelossi; G Dal Molin; N Di Toro; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2009-11-12       Impact factor: 4.330

Review 6.  The adaptive immune response in celiac disease.

Authors:  Shuo-Wang Qiao; Rasmus Iversen; Melinda Ráki; Ludvig M Sollid
Journal:  Semin Immunopathol       Date:  2012-04-26       Impact factor: 9.623

7.  The intestinal B-cell response in celiac disease.

Authors:  Luka Mesin; Ludvig M Sollid; Roberto Di Niro
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

8.  Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.

Authors:  Paolo Durigutto; Paolo Macor; Federica Ziller; Luca De Maso; Fabio Fischetti; Roberto Marzari; Daniele Sblattero; Francesco Tedesco
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 9.  Animal models to study gluten sensitivity.

Authors:  Eric V Marietta; Joseph A Murray
Journal:  Semin Immunopathol       Date:  2012-05-11       Impact factor: 11.759

Review 10.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.